NASDAQ:SNDX - Syndax Pharmaceuticals SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$5.18 +0.06 (+1.17 %)
(As of 03/19/2019 06:00 AM ET)
Previous Close$5.12
Today's Range$5.06 - $5.32
52-Week Range$3.39 - $15.20
Volume104,100 shs
Average Volume141,867 shs
Market Capitalization$129.51 million
P/E Ratio-1.77
Dividend YieldN/A
Beta2.41

SEC Filings

Syndax Pharmaceuticals (NASDAQ:SNDX) SEC Filings

DateFilerForm TypeView
03/18/2019
3:52 PM
Syndax Pharmaceuticals (Filer)
Form 10-K/A
View Filing
03/07/2019
3:10 PM
Syndax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/14/2019
3:22 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Syndax Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/14/2019
10:41 AM
683 Capital Management, LLC (Filed by)
Syndax Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/12/2019
3:02 PM
Syndax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/12/2019
8:50 AM
Syndax Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/08/2019
3:28 PM
Ordentlich Peter (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2019
3:27 PM
Shea Richard P (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2019
3:27 PM
Meyers Michael L. (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2019
3:27 PM
Metzger Michael A (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/29/2018
3:03 PM
683 Capital Management, LLC (Filed by)
Syndax Pharmaceuticals (Subject)
Form SC 13G
View Filing
11/07/2018
3:02 PM
Meyers Michael L. (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/05/2018
4:01 PM
Syndax Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
11/05/2018
3:02 PM
Syndax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/27/2018
4:42 PM
Jarrett Jennifer (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/27/2018
4:42 PM
Meury William (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/27/2018
4:38 PM
Jarrett Jennifer (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/27/2018
4:38 PM
Meury William (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/26/2018
3:02 PM
Syndax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/29/2018
2:01 PM
Syndax Pharmaceuticals (Filer)
Form CT ORDER
View Filing
08/08/2018
3:16 PM
Syndax Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/07/2018
3:02 PM
Syndax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/20/2018
6:48 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/20/2018
3:34 PM
Syndax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/13/2018
4:15 PM
Syndax Pharmaceuticals (Filer)
Form CT ORDER
View Filing
05/25/2018
8:00 AM
Chen Henry (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/25/2018
8:00 AM
Egros Fabrice (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/25/2018
8:00 AM
EVNIN LUKE (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/25/2018
8:00 AM
Katkin Keith (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/25/2018
7:59 AM
Legault Pierre (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/25/2018
7:59 AM
Podlesak Dennis (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/25/2018
5:00 AM
Syndax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/09/2018
3:02 PM
Syndax Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/08/2018
3:02 PM
Syndax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/10/2018
3:06 PM
Syndax Pharmaceuticals (Filer)
Form DEFA14A
View Filing
04/10/2018
3:06 PM
Syndax Pharmaceuticals (Filer)
Form DEF 14A
View Filing
04/03/2018
3:42 PM
Ordentlich Peter (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/03/2018
1:45 PM
Syndax Pharmaceuticals (Filer)
Form CT ORDER
View Filing
03/08/2018
3:06 PM
Syndax Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/06/2018
3:02 PM
Syndax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/05/2018
3:04 PM
Shea Richard P (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2018
3:04 PM
Ordentlich Peter (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/14/2018
1:50 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Syndax Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/12/2018
3:01 PM
Podlesak Dennis (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/12/2018
3:01 PM
Legault Pierre (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/12/2018
3:01 PM
Katkin Keith (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/12/2018
3:00 PM
EVNIN LUKE (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/12/2018
3:00 PM
Egros Fabrice (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/12/2018
3:00 PM
Chen Henry (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/02/2018
12:15 PM
MPM BioVentures IV QP LP (Filed by)
Syndax Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
12/11/2017
9:37 AM
FMR LLC (Filed by)
Syndax Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
12/08/2017
6:01 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Syndax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
12/07/2017
1:16 PM
BlackRock Inc. (Filed by)
Syndax Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
This page was last updated on 3/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel